Please enable JavaScript to view this page correctly
Apoptosis and survival_Anti-apoptotic action of nuclear ESR1 and ESR2
Estradiol exerts an anti-apoptotic
effect on a wide variety of tissues that is mediated via activation of nuclear form of
ESR1 (nuclear) and ESR2 [1 ], [2 ]. Under Estradiol action, ESR1 (nuclear)
induces transcription of Bcl-2
[2 ], [3 ], [4 ].
Upon activation by Estradiol , ESR2
promotes anti-apoptotic action via induction
of expression of nNOS and synthesis
of NO , which leads to activation of
Guanylate Cyclase 1, soluble , release of
Cyclic GMP , and activation of Protein kinase
cGMP-dependent (e.g., Protein kinase G1 )
[1 ], [2 ], [5 ]. Protein kinase G1 activates ERK1/2 possibly via c-Raf-1 / MEK1(MAP2K1) and MEK2(MAP2K2) pathway, and leads to activation of c-Myc and c-Jun transcription
factors, which induce transcription of Thioredoxin
(c-Jun acts as a part of
c-Jun/c-Fos heterodimer) [6 ], [7 ], [8 ].
Thioredoxin
binds to NF-kB1 (p50) and
activates transcription of anti-apoptotic Bcl-2 ,
which inhibits formation of mitochondrial permeability transition pore by
Bax , and SOD2 . This leads to decrease in mitochondrial Superoxide anion production
during apoptosis [2 ], [7 ], [9 ].
Moreover, reduced form of Thioredoxin binds and inhibits pro-apoptotic kinase
ASK1 (MAP3K5) [10 ], [11 ] which prevents activation of MEK3(MAP2K3) , MEK4(MAP2K4) ,
then p38alpha (MAPK14) and subsequently,
JNK1(MAPK8) [12 ]. Thus, inhibited
p38alpha (MAPK14) and JNK1(MAPK8) both cannot promote
inhibition of Bcl-2 , so it prevents formation of
mitochondrial permeability transition pore by Bax and release of Cytochrome c
from mitochondria [12 ].
Objects list:
ASK1 (MAP3K5)
Mitogen-activated protein kinase kinase kinase 5
Bax
Apoptosis regulator BAX
Bcl-2
Apoptosis regulator Bcl-2
Cyclic GMP
Chemical IUPAC name Guanosine 3',5'-cyclic phosphate
Cytochrome c
Cytochrome c
ERK1/2
Erk 1/2 Protein group
ESR1 (nuclear)
Estrogen receptor
ESR2
Estrogen receptor beta
Estradiol
Chemical IUPAC name (8R,9S,13S,14S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
Guanylate Cyclase 1, soluble
soluble Guanylate Cyclase Group of complexes
JNK1(MAPK8)
Mitogen-activated protein kinase 8
MEK1(MAP2K1)
Dual specificity mitogen-activated protein kinase kinase 1
MEK2(MAP2K2)
Dual specificity mitogen-activated protein kinase kinase 2
MEK3(MAP2K3)
Dual specificity mitogen-activated protein kinase kinase 3
MEK4(MAP2K4)
Dual specificity mitogen-activated protein kinase kinase 4
NF-kB1 (p50)
Nuclear factor NF-kappa-B p50 subunit
NO
Chemical IUPAC name Nitric oxide
Protein kinase G1
cGMP-dependent protein kinase 1
SOD2
Superoxide dismutase [Mn], mitochondrial
Thioredoxin
Thioredoxin
c-Jun
Transcription factor AP-1
c-Jun/c-Fos
c-Jun/c-Fos Complex
c-Myc
Myc proto-oncogene protein
c-Raf-1
RAF proto-oncogene serine/threonine-protein kinase
nNOS
Nitric oxide synthase, brain
p38alpha (MAPK14)
Mitogen-activated protein kinase 14
Lee SY, Andoh T, Murphy DL, Chiueh CC
17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003 May;17(8):947-8
Chiueh C, Lee S, Andoh T, Murphy D
Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen.
Endocrine 2003 Jun;21(1):27-31
Perillo B, Sasso A, Abbondanza C, Palumbo G
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.
Molecular and cellular biology 2000 Apr;20(8):2890-901
Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD
Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function.
BMC neuroscience 2006 Nov 3;7:74
Wen Y, Perez EJ, Green PS, Sarkar SN, Simpkins JW
nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells.
Neuroreport 2004 Jun 28;15(9):1515-8
Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J
Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors.
The Journal of biological chemistry 2001 May 25;276(21):18399-406
Andoh T, Chiueh CC, Chock PB
Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis.
The Journal of biological chemistry 2003 Jan 10;278(2):885-90
Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B
Genomic targets of the human c-Myc protein.
Genes & development 2003 May 1;17(9):1115-29
Das KC, Lewis-Molock Y, White CW
Elevation of manganese superoxide dismutase gene expression by thioredoxin.
American journal of respiratory cell and molecular biology 1997 Dec;17(6):713-26
Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.
The EMBO journal 1998 May 1;17(9):2596-606
Satoh M, Matter CM, Ogita H, Takeshita K, Wang CY, Dorn GW 2nd, Liao JK
Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Circulation 2007 Jun 26;115(25):3197-204
Nishida K, Otsu K
The role of apoptosis signal-regulating kinase 1 in cardiomyocyte apoptosis.
Antioxidants & redox signaling 2006 Sep-Oct;8(9-10):1729-36
Developed by WaveAccess